resisttb
- Dec 1, 2021
- 1 min read

South Africa sets another example of success in beating tuberculosis

During the Union’s 52nd World Conference on Lung Health in late October, Doctors Without Borders (MSF) announced the results of TB-PRACTEAL, the first multi-country randomized controlled clinical trial to report on the efficacy and safety of a multidrug-resistant tuberculosis (MDR-TB) treatment. Time has shown that MDR-TB is a very difficult form of tuberculosis to treat, requiring multidrug therapies to be administered over a period of nine to 24 months. Read Here.

Recent Posts

See All

New blood test can help doctors diagnose TB and monitor treatment

Researchers at Tulane University School of Medicine have developed a new highly sensitive blood test for tuberculosis (TB) that screens for DNA fragments of the Mycobacterium tuberculosis bacteria tha

WHO issues rapid communication on updated guidance for the treatment of drug-resistant tuberculosis

A rapid communication released by the World Health Organization (WHO) Global Tuberculosis Programme has announced upcoming updates to the guidance on the treatment of drug-resistant tuberculosis (DR-T

20% of multi-drug resistant tuberculosis cases in children could be averted by household testing

One in five multi-drug resistant (MDR) tuberculosis (TB) cases in children under the age of 15 could be averted every year by household contact management, according to a new modelling study published